Hempmon Profile

Founded in October 2017, Yunnan Hempmon Pharmaceuticals Co.,Ltd. is a subsidiary of Chengzhi Shareholding Co., Ltd., an affiliate of Tsinghua Holdings. Hempmon CZ is located in Yunnan province's Guandu Industrial Park, a key investment project in one of China's new urban districts.

Hempmon CZ has built a hemp processing plant in strict compliance with international GMP standards and BRC Global Standards for Food Safety. With a building area of 60,000 square meters, the plant's facilities include a hemp extraction and processing workshop, smart integrated warehousing system, health products and pharmaceutical preparation workshop, engineering technology center, quality control center, demonstration plant factory and hemp museum.

The processing plant is equipped with smart manufacturing equipment, intelligent manufacturing execution system (MES) and smart warehouse management system (WMS) that meet the requirements of the Made in China 2025 strategic plan. With a numerical control rate of over 90%, our smart production system enables automated and digital separation, purification, and mass production of various non-psychoactive cannabinoids, including cannabidiol (CBD) and broad-spectrum hemp oil, before they are delivered to companies across the world. Featuring industry-leading production quality, production efficiency and energy utilization, the plant is a global hemp processing base and industrial complex integrating advanced technology, efficient production, green development and smart manufacturing.


R&D Centers


Research Areas


Categories of Core Products

Core Products
Corporate Strength

On May 18, 2021, Yunnan Hempmon Pharmaceuticals Co., Ltd. (hereinafter referred to as “Hempmon CZ”) won the “2020 Enterprise Award in Technological Innovation”.

Hempmon CZ attaches great importance to scientific and technological innovation ...


On October 19, 2020, according to the announcement released by Yunnan Provincial Science and Technology Department, Yunnan Hempmon Pharmaceuticals Co., Ltd. (hereinafter referred to as “Hempmon CZ”) has passed the filing review process and recognized a...


Recently, Yunnan Hempmon Pharmaceuticals Co., Ltd. (hereinafter referred to as “Hempmon CZ”)’s annual extraction and processing project of 2,000 tons of hemp has been recognized as the pilot demonstration project of “Industrialization, Standardization ...